Azithromycin Tablets Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP manufactures Azithromycin Tablets for treatment of bacterial infections involving the respiratory tract, throat, lungs, ears, and skin. The formulation is frequently used in bronchitis, sinusitis, tonsillitis, pneumonia, and bacterial ENT infection therapies.

Azithromycin belongs to the macrolide antibiotic group and works by inhibiting bacterial protein synthesis, preventing bacterial growth and multiplication. Recognized as an Azithromycin Tablets Manufacturer in India, Genliva Wellness LLP develops oral antibiotic formulations with consistent dissolution and dependable antibacterial effectiveness.

Serving pharmaceutical distribution and export-focused healthcare markets, Genliva Wellness LLP is also known as an Azithromycin Tablets Exporter supplying oral antibacterial medicines to international pharmaceutical buyers and healthcare institutions.

Azithromycin Tablets are formulated for oral macrolide antibacterial treatment.

Macrolide antibiotic tablet formulation
Effective against respiratory and ENT infections
Controls bacterial growth and multiplication
Stable oral tablet dosage form
Manufactured using quality pharmaceutical ingredients
Designed for bacterial infection therapies

This formulation is commonly used for respiratory and bacterial infection treatment.

Treatment of throat and respiratory infections
Management of bronchitis and sinusitis
Used in pneumonia and ENT infection therapies
Controls bacterial infection progression effectively
Improves recovery from infectious diseases
Used in oral antibiotic treatment protocols

Azithromycin Tablets provide broad antibacterial coverage for respiratory infection treatment.

Effective in throat and chest infection care
Helps reduce bacterial growth rapidly
Useful in sinus and ENT infection treatment
Convenient oral tablet administration
Provides dependable macrolide antibacterial action
Suitable for routine bacterial infection therapies